Trials / Completed
CompletedNCT02740621
The Impact of Opioids in Coronary Heart Disease
Evaluation of Past Medications in Patients With Coronary Heart Disease and Patients Hospitalized for a Non-cardiac Reason
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (actual)
- Sponsor
- Ruhr University of Bochum · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the risk of opioid medications on coronary heart disease in adults is investigated. Patients with the necessity of a coronary angiography and control patients with a non-cardiac disease of the same hospital are inquired with a standardized questionnaire about demographic and clinical risk factors for heart attack. An impact of opioid medications on coronary heart disease is hypothesised (MIOP). In addition, all patients with coronary angiography should be consulted twice (after 3 and 6 months) to find out how many of these patients have developed a refractory angina pectoris (TRAPS).
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-08-01
- First posted
- 2016-04-15
- Last updated
- 2018-04-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02740621. Inclusion in this directory is not an endorsement.